Fresenius Medical Care AG & Co KGaA ST buy ler
Summary
This prediction ended on 06.11.14 with a price of €57.46. With a performance of 5.62%, the BUY prediction by ler for Fresenius Medical Care AG & Co KGaA ST closed with a slight gain. ler has 50% into this predictionFresenius Medical Care is a leading global provider of dialysis products, services and care, particularly for patients with chronic kidney disease. It operates in over 120 countries and cares for over 345,000 patients worldwide. The company specializes in renal care, manufacturing and distributing products related to dialysis and providing clinical care as well as education and support services for patients with kidney disease. Fresenius Medical Care has been listed on the Frankfurt Stock Exchange since 1996 and on the New York Stock Exchange since 1997. Its symbol, FMCQF, represents its over-the-counter (OTC) stock symbol in the United States.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Fresenius Medical Care AG & Co KGaA ST | 0.053% | 0.053% | -7.074% | -38.034% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% | 22.236% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% | 42.175% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% | 6.454% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% | 42.672% |
Comments by ler for this prediction
In the thread Fresenius Medical Care AG & Co KGaA ST diskutieren
Aktueller Zukauf in den USA
Dieser Zukauf ergänzt das Business Model: daher ist die Aktie ein strategischer Kauf.
Stopped prediction by ler for Fresenius Medical Care AG & Co KGaA ST
Fresenius Medical Care AG & Co KGaA ST
04.07.18
04.11.21
05.11.21